about
The Warburg effect and drug resistanceExtracellular nicotinamide phosphoribosyltransferase, a new cancer metabokineApplications of chemogenomic library screening in drug discoveryBiased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonistsThe evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21.Pharmacogenomics of off-target adverse drug reactions.Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasisPharmacokinetics of obinutuzumab in Chinese patients with B-cell lymphomas.Population pharmacokinetics of rituximab in patients with diffuse large B-cell lymphoma and association with clinical outcomeRedox-based therapeutics in neurodegenerative disease.Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment.Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.Development of an in vivo target-engagement biomarker for TRPA1 antagonists in humans.Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore.Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study.Possible pharmacotherapy for nifedipine-induced gingival overgrowth: 18α-glycyrrhetinic acid inhibits human gingival fibroblast growth.Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitisEffects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes.Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity.Inhibition of fatty acid synthase is protective in pulmonary hypertension.Antagonizing midkine accelerates fracture healing in mice by enhanced bone formation in the fracture callusAnti-oxidative effect of AST-120 on kidney injury after myocardial infarction.Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularization.Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator.Accelerating the search for the missing proteins in the human proteome.Decursin enhances TRAIL-induced apoptosis through oxidative stress mediated- endoplasmic reticulum stress signalling in non-small cell lung cancersMadecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon.GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes.Anti-CD22 and anti-CD79b antibody-drug conjugates preferentially target proliferating B cells.Curcumin Ameliorates Cisplatin-Induced Nephrotoxicity and Potentiates Its Anticancer Activity in SD Rats: Potential Role of Curcumin in Breast Cancer Chemotherapy.Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.Protein S-sulfhydration by hydrogen sulfide in cardiovascular system.Microglia antioxidant systems and redox signalling.COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels.Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy.
P2860
Q26770007-0D2A52F8-AB6A-4726-9454-EF898264E627Q28069876-88C4FEA7-3355-4865-AFE9-7A08987DD458Q28656335-3C9D92BA-9602-4F02-8BC6-EF7AC390EB88Q30359656-F18BDC58-7E33-488D-9AC6-EB67A483F7C7Q30397640-9DF47EE4-4CB7-425C-856D-8C317724E6C6Q30400366-3F0D30E0-8B20-49B3-886D-3FBABF137FAAQ33434017-E5239F66-D261-45F9-A844-5FC18DDFD2A0Q33593625-7E94DBBA-6A23-4B45-B032-4E409D5E5DE8Q33780903-7EC83B5D-E9CF-4B46-B5D4-FFF1E65CEE45Q33903709-0DB5D55B-EE1F-4523-B1B9-F133BCCAC318Q34535918-DBD0AB4B-67B3-49D7-9561-7D13619FFA6CQ34556039-9803FD54-8CFF-4DBB-B58E-8843D550067BQ34680436-7CB462E9-5790-4EEB-B568-59B07BEE6DC1Q36091331-7BA09D67-7FB8-4DAD-A4EC-2D1CEF281DABQ36148650-0530025C-5D95-4872-A070-3E82284A317DQ36261948-F29DBCD2-A4C0-41D1-877B-1E36F9D94067Q36298544-BBA9F6E4-22F2-4044-8C02-7EA4DFCDFDC4Q36310002-F6011D2D-0A06-4311-9CC1-6FAE7AC606EEQ36599652-305BB931-3816-430E-83B8-08B857044854Q36797398-4EA4489B-EBCF-45C3-9B9F-6BC72CCE5FCEQ36830128-79C6CB62-8F65-4BB4-9F91-3650EC985397Q36903400-3EE27117-A74A-4540-87CE-CBFBB87F7799Q36903419-B6449D79-79B2-49DE-8D93-0371E22D0A17Q36941262-03AD3FB9-DC30-4505-8A6D-7AF64FE556D3Q37034753-336B4099-BC38-4D34-B1B3-B5E5CCA5306FQ37084883-B6C0FED4-152E-4BD3-A673-494665985D4BQ37320992-905E7C0A-E0A3-4A4C-A029-4B553A169F39Q37587285-FA086F87-BD0D-46F7-9089-B0C83070701BQ37617923-E6769ED0-33B4-47F2-BB13-FE79CAF0C017Q37686138-94E153ED-6348-4E32-A975-A20F3C6B57F2Q37686310-EE7B9FE0-6AE2-4123-8330-218BD6B7420EQ37695053-12ADCDE5-B368-4C53-891B-1A8080A92D3EQ37723164-BABC1CDA-E177-4A80-8E33-0B8407773D86Q37736102-7D464726-665D-4CE4-8795-4CEA420241AAQ38430705-FCC3AE2B-412F-40AE-909F-28B3A31E71C9Q38692090-359469BE-0DA6-40E9-ABE6-545175ACF6C5Q38692790-8337FBA2-CB4C-472B-B1DF-442BEF4158E9Q38701659-6304C8AF-EAE3-4C22-93C3-C3B3D278BBDEQ38708465-80A998A0-684F-433F-9D49-87B5132B0D48Q38714006-E2BA8108-AE4C-470B-BD3B-1AF1B3CCE4D4
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Concise Guide to PHARMACOLOGY 2015/16: Overview
@ast
The Concise Guide to PHARMACOLOGY 2015/16: Overview
@en
type
label
The Concise Guide to PHARMACOLOGY 2015/16: Overview
@ast
The Concise Guide to PHARMACOLOGY 2015/16: Overview
@en
prefLabel
The Concise Guide to PHARMACOLOGY 2015/16: Overview
@ast
The Concise Guide to PHARMACOLOGY 2015/16: Overview
@en
P2093
P50
P356
P1476
The Concise Guide to PHARMACOLOGY 2015/16: Overview
@en
P2093
CGTP Collaborators
Doriano Fabbro
Eamonn Kelly
Helen E Benson
John A Peters
John C McGrath
Michael Spedding
Neil Marrion
O Peter Buneman
P304
P356
10.1111/BPH.13347
P407
P50
P577
2015-12-01T00:00:00Z